The merger is complete and the stock will be delisted. Traders holding APGE shares should have already tendered them for the $135.11 cash consideration. There is no further trading opportunity in APGE; any remaining positions should be settled through the merger consideration process.
Price Chart
Executive Summary
Apogee Therapeutics has been acquired by AbbVie in a completed all-cash merger valued at approximately $10.9 billion. Shareholders received $135.11 per share in cash, and the company's stock will be delisted from Nasdaq effective September 4, 2026. This 25-NSE filing is the formal notification by Nasdaq of the removal from listing and registration of Apogee's common stock, confirming the completion of the merger and the end of public trading in APGE shares.
Key Facts
- Apogee Therapeutics has been acquired by AbbVie in a completed all-cash merger valued at approximately $10.9 billion.
- Shareholders received $135.11 per share in cash.
- The company's stock will be delisted from Nasdaq effective September 4, 2026.
- This 25-NSE filing is the formal notification by Nasdaq of the removal from listing and registration of Apogee's common stock.
- The filing confirms the consummation of the previously announced merger, resulting in a change of control and the termination of all pre-merger equity plans.
Financial Impact
All-cash merger valued at approximately $10.9 billion, with shareholders receiving $135.11 per share.
Risk Factors
- No further trading opportunity in APGE shares; delisting is effective immediately.
- Any remaining shareholders who have not tendered shares may face delays or additional steps to receive the merger consideration.
- The merger consideration is fixed at $135.11 per share; there is no upside beyond this amount.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000853 |
| Document: 0001354457-26-000853-index-headers.html | 0001354457-26-000853 |
| Document: 0001354457-26-000853-index.html | 0001354457-26-000853 |
| Document: 0001354457-26-000853.txt | 0001354457-26-000853 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 15-12G | โ | awaiting T+5 | โ | โ |
Sep 3, 2026 29d ago | 25-NSE | $135.06 awaiting T+5 | awaiting T+5 | โ | โ |
Sep 3, 2026 29d ago | 8-K | $135.06 awaiting T+5 | awaiting T+5 | โ | โ |
Aug 11, 2026 7w ago | 8-K | $134.55 $134.71 | โฒ +0.12% | โฒ +0.56% | โ |
Aug 10, 2026 7w ago | 8-K | $134.65 $134.59 | โผ โ0.04% | โฒ +0.00% | โ |
Aug 10, 2026 7w ago | Press Release | $134.65 $134.59 | โผ โ0.04% | โฒ +0.00% | โ |
Aug 6, 2026 8w ago | Institutional Cluster | $134.49 $134.45 | โผ โ0.03% | โผ โ1.24% | โ |
Aug 3, 2026 8w ago | DEFA14A | $134.19 $134.69 | โฒ +0.37% | โฒ +0.47% | โ |
Jul 11, 2026 11w ago | Insider Cluster | $133.82 $134.00 | โฒ +0.13% | โฒ +0.92% | โ |
Jun 26, 2026 13w ago | DEFA14A | $132.61 $133.50 | โฒ +0.67% | โผ โ0.72% | โ |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access